Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Aasander Frostner 2022 Abstract Bioblast

From Bioblast

Bioblast2022 banner.jpg

8.1. «10+5»
Åsander Frostner Eleonor
Åsander Frostner Eleonor, Simón Serrano S, Chamkha I, Donnelly E, Elmér E, Hansson MJ (2022) Towards a treatment for mitochondrial disease: current compounds in clinical development.
Bioblast 2022: BEC Inaugural Conference. In:
»Bioenergetics Communications« »Watch the presentation«

Link: Bioblast 2022: BEC Inaugural Conference

Aasander Frostner Eleonor, Simon Serrano Sonia, Chamkha Imen, Donnelly Ellen, Elmer Eskil, Hansson Magnus J (2022)

Event: Bioblast 2022

Primary mitochondrial diseases are a heterogeneous group of rare genetic disorders affecting approximately 125 persons per million. Mutations underlying these diseases give rise to biological changes (including decrease in cellular energy production and increase in reactive oxygen species), leading to organ failure, and commonly early morbidity. Mitochondrial diseases often present in early childhood and lead to the development of severe symptoms, with severe fatigue and myopathy being some of the most prevalent and debilitating clinical signs.

There are currently no cures for mitochondrial diseases, nor any approved pharmaceutical treatments for multisystemic disorders.

Current drug development in mitochondrial diseases focuses mainly on modulation of oxidative stress, regulation of the expression of genes involved in metabolic pathways, modulation of coenzymes, induction of mitochondrial biogenesis, and energy replacement.

In this short review, we present the current landscape of mitochondrial disease drug development, focusing on small molecules in clinical trials conducted by industrial sponsors.

Keywords: mitochondria, primary mitochondrial disease, genetic disorders, MELAS, myopathy

O2k-Network Lab: SE Lund Elmer E


Åsander Frostner E1,2, Simón Serrano S1,2, Chamkha I1,2, Donnelly E1, Elmér E1,2, Hansson MJ1,2
  1. Abliva AB, Medicon Village, 223 81 Lund, Sweden
  2. Mitochondrial Medicine, Department of Clinical Sciences Lund, Lund University, Lund, Sweden

List of abbreviations, terms and definitions - MitoPedia

» MitoPedia: Terms and abbreviations

Labels: MiParea: mt-Medicine, Pharmacology;toxicology  Pathology: Inherited  Stress:Mitochondrial disease  Organism: Human 

Event: B4